DK158770C - Anvendelse af paroxetin til fremstilling af medikament mod fedme - Google Patents

Anvendelse af paroxetin til fremstilling af medikament mod fedme

Info

Publication number
DK158770C
DK158770C DK562585A DK562585A DK158770C DK 158770 C DK158770 C DK 158770C DK 562585 A DK562585 A DK 562585A DK 562585 A DK562585 A DK 562585A DK 158770 C DK158770 C DK 158770C
Authority
DK
Denmark
Prior art keywords
medicine
paroxetin
preparation
application
medicine medicine
Prior art date
Application number
DK562585A
Other languages
Danish (da)
English (en)
Other versions
DK158770B (da
DK562585D0 (da
DK562585A (da
Inventor
Joergen Buus Lassen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of DK562585D0 publication Critical patent/DK562585D0/da
Publication of DK562585A publication Critical patent/DK562585A/da
Publication of DK158770B publication Critical patent/DK158770B/da
Application granted granted Critical
Publication of DK158770C publication Critical patent/DK158770C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK562585A 1984-12-04 1985-12-04 Anvendelse af paroxetin til fremstilling af medikament mod fedme DK158770C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848430581A GB8430581D0 (en) 1984-12-04 1984-12-04 Treatment
GB8430581 1984-12-04

Publications (4)

Publication Number Publication Date
DK562585D0 DK562585D0 (da) 1985-12-04
DK562585A DK562585A (da) 1986-06-05
DK158770B DK158770B (da) 1990-07-16
DK158770C true DK158770C (da) 1991-01-07

Family

ID=10570670

Family Applications (1)

Application Number Title Priority Date Filing Date
DK562585A DK158770C (da) 1984-12-04 1985-12-04 Anvendelse af paroxetin til fremstilling af medikament mod fedme

Country Status (8)

Country Link
US (1) US4745122A (cs)
EP (1) EP0188081B1 (cs)
JP (1) JPS61148121A (cs)
AU (1) AU580820B2 (cs)
DE (1) DE3585607D1 (cs)
DK (1) DK158770C (cs)
GB (1) GB8430581D0 (cs)
ZA (1) ZA859286B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US4971974A (en) * 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
US5900418A (en) * 1997-02-10 1999-05-04 Synapse Pharmaceuticals International, Inc. Method for treatment of obesity
TR199903025T2 (xx) 1997-06-10 2000-07-21 Synthon B.V. 4-Fenilpiperidin bile�imleri.
PL342295A1 (en) * 1998-02-06 2001-06-04 Smithkline Beecham Plc Paroxetin salts
US20030028027A1 (en) * 1998-04-09 2003-02-06 Smithkline Beecham Plc Paroxetine maleate
GB9808894D0 (en) * 1998-04-25 1998-06-24 Smithkline Beecham Plc Novel compound
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9814316D0 (en) * 1998-07-02 1998-09-02 Smithkline Beecham Plc Novel compounds
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
WO2000008016A1 (en) * 1998-08-08 2000-02-17 Smithkline Beecham Plc Paroxetine salts
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
EP1408039A3 (en) * 1998-11-30 2004-05-12 Smithkline Beecham Plc Mixed paroxetine propan-2-ol solvates
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9827431D0 (en) * 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
KR20050044533A (ko) * 2001-11-19 2005-05-12 엘란 파마슈티칼스, 인크. 알츠하이머병을 치료하기 위한 베타-세크레타아제억제제로서의（４-페닐）피페리딘-３-일-페닐카르복실레이트유도체 및 관련 화합물
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
EP1843819A2 (en) * 2004-11-15 2007-10-17 Obe Therapy Biotechnology S.A.S. Methods of reducing body fat
JP5301991B2 (ja) * 2005-07-29 2013-09-25 コンサート ファーマシューティカルズ インコーポレイテッド 新規なベンゾ［ｄ］［１，３］−ジオキソール誘導体
DK2225261T3 (en) 2007-12-03 2016-06-06 Obe Therapy Biotechnology Borpeptidinhibitorer of enteropeptidase and their uses in the treatment of obesity, obesity and / or disorders associated with abnormal lipid metabolism
TW201212918A (en) * 2010-08-23 2012-04-01 Lundbeck & Co As H Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
CH583730A5 (cs) * 1973-09-25 1977-01-14 Wander Ag Dr A
US4442113A (en) * 1981-05-07 1984-04-10 A/S Ferrosan Long-term weight reduction of obese patients using femoxetine

Also Published As

Publication number Publication date
EP0188081B1 (en) 1992-03-11
DK158770B (da) 1990-07-16
AU580820B2 (en) 1989-02-02
EP0188081A3 (en) 1989-10-11
JPS61148121A (ja) 1986-07-05
JPH0586763B2 (cs) 1993-12-14
DE3585607D1 (de) 1992-04-16
DK562585D0 (da) 1985-12-04
EP0188081A2 (en) 1986-07-23
DK562585A (da) 1986-06-05
GB8430581D0 (en) 1985-01-09
ZA859286B (en) 1986-11-26
AU5074985A (en) 1986-06-12
US4745122A (en) 1988-05-17

Similar Documents

Publication Publication Date Title
DK158770C (da) Anvendelse af paroxetin til fremstilling af medikament mod fedme
DK186786D0 (da) Fremgangsmaade til fremstilling af polymerpolyahler
DK186886A (da) Fremgangsmaade til fremstilling af polymerpolyahler
DK119086D0 (da) Fremgangsmaade til fremstilling af oligonucleotider
NO169126C (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin
DK214585D0 (da) Fremgangsmaade til fremstilling af imidazorifamyciner
DK28788D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK287484D0 (da) Fremgangsmaade til fremstilling af acetaldehyd
DK184687A (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK533287A (da) Fremgangsmaade til fremstilling af azetidinoner
DK605384A (da) Fremgangsmaade til fremstilling af azetidinoner
DK258886D0 (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK157874C (da) Fremgangsmaade til fremstilling af azinomethylrifamyciner
DK509986D0 (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK564985D0 (da) Fremgangsmaade til fremstilling af alkylthioacetamidiner
DK291785A (da) Fremgangsmaade til fremstilling af iminderivater
DK234687A (da) Fremgangsmaade til fremstilling af ribitylxylidin
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK61091A (da) Fremgangsmaade til fremstilling af 4-phenylpiperidinderivater
DK390887A (da) Fremgangsmaade til fremstilling af 7alfa-acetylthiosteroider
DK105586A (da) Fremgangsmaade til fremstilling af benzylidenforbindelser
DK375687D0 (da) Fremgangsmaade til fremstilling af alfa-hydroxycarbonylforbindelser
DK646188D0 (da) Fremgangsmaade til fremstilling af halogenalkyllactamer
DK64085D0 (da) Fremgangsmaade til fremstilling af imidazolderivater

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK